Treatment of immunoglobulin G4-related sialadenitis: outcomes of glucocorticoid therapy combined with steroid-sparing agents

BACKGROUND: Immunoglobulin G4-related sialadenitis (IgG4-RS) is a newly recognized immune-mediated systemic disease. Despite its good response to steroid therapy, its treatment protocol is not standardized and the long-term outcome is controversial. The study was conducted to determine the short-ter...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Xia, Zhang, Yan-Yan, Li, Wei, Liu, Yan-Ying, Wang, Zhen, Chen, Yan, Gao, Yan, Sun, Zhi-Peng, Peng, Xin, Su, Jia-Zeng, Cai, Zhi-Gang, Zhang, Lei, He, Jing, Ren, Li-Min, Yang, Hong-Yu, Li, Zhan-Guo, Yu, Guang-Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791187/
https://www.ncbi.nlm.nih.gov/pubmed/29382364
http://dx.doi.org/10.1186/s13075-017-1507-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791187/
https://www.ncbi.nlm.nih.gov/pubmed/29382364
http://dx.doi.org/10.1186/s13075-017-1507-6

Ejemplares similares